Informations générales (source: ClinicalTrials.gov)
Screening for Cancers in the Oral CAvity Targeting Tobacco Users in Somme, France (IDECAB)
Interventional
N/A
Centre Hospitalier Universitaire, Amiens (Voir sur ClinicalTrials)
octobre 2013
décembre 2028
29 juin 2024
In the Somme region of France, cancer registry data showed an increasing incidence of
oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral
Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100
000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to
improve early detection for smokers will be assessed. This target population consults
late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This
project is an innovative incentive strategy for screening among general practitioners
based on unusual information vectors (tobacconist, local media).
The main objective of this study is a screening of oral cavity cancers in tobacco users
aged 30-75 years in the Somme region of France.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Amiens University Hospital - 80054 - Amiens - Picardie - France | Bernard DEVAUCHELLE, MD, phD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco
shop located on the territory of the Somme
- lives in somme departement
- Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco
shop located on the territory of the Somme
- lives in somme departement
-